08: Developing a Strategic Mindset With Bill Adams

Strategic Financial Leadership

In this episode of Strategic Financial Leadership Steve talked with Bill Adams about how to move from a transactional role to a thought leadership position that drives meaningful value. Bill is the Chief Financial Officer of NervGen Pharma Corp., a publicly-traded regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage. In his previous companies, Bill has raised over $250 million in public and private equity financing and has engaged in over $750 million in mergers and acquisition and technology licensing transactions. His experience in M&A, operations, and capital markets both in Canada and the United States has made Bill a critical asset to NervGen as it continues to build a world-class company creating new therapies for spinal cord injury and neurodegenerative diseases. Bill continues to be successful as a CFO because of his strategic mindset and integrative approach to finance.
Helpful links:

• Free masterclass for business leaders and entrepreneurs: The Surprising Path to Excellence
• Take our free Performance Health Score Assessment. Start here
• Download the FREE Boosting Your Financial IQ app at the Apple App Store or Google Play Store
• Join our SFL Accelerator Program
• Check out our free masterclass "The Surprising Path to Excellence".

Disclaimer:
BYFIQ, LLC is a wholly owned entity of Coltivar Group, LLC. The views expressed here are those of the individual Coltivar Group, LLC (“Coltivar”) personnel quoted and are not the views of Coltivar or its affiliates. Certain information contained in here has been obtained from third-party sources. While taken from sources believed to be reliable, Coltivar has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.
This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendations. The Company is not affiliated with, nor does it receive compensation from, any specific security. Please see https://www.byfiq.com/terms-and-privacy-policy for additional important information.